January 2019

Letter from the Editor

January 1, 2019

Artificial Intelligence Happy New Year. As we enter 2019, we take note of one of the major trends expected to impact all aspects of the life-sciences industry: artificial intelligence. In 2019, according to Forrester, AI solutions will continue to spread across the healthcare continuum thanks to the promise of improved experiences and outcomes. The key […]

Upfront

January 1, 2019

Medicinal Theater BioMarin Pharmaceutical and Believe Ltd. sponsored a first-of-its-kind theatrical production for teenagers with hemophilia. The musical, Hemophilia: The Musical, took place at New World Stages on Nov. 12, 2018. Before the performance, students participated in the Breaking Through! Musical Theater Intensive, a three-day workshop that included coaching sessions on the impact of breathing […]

HealthTech

January 1, 2019

Payers Use Healthtech to Improve Patient Outcomes, Lower Costs Trend Watch: Healthtech Mobile App Market Continues To Grow Payers Offer Free Wearables UnitedHealthcare, Aetna, and John Hancock have all implemented programs that offer free Apple Watches to customers, if they exercise daily. The latest organization to announce its plan, UnitedHealthcare, is offering the option to […]

Artificial Intelligence

January 1, 2019

Artificial Intelligence Key to Improving Healthcare Quality, Reducing Costs Trend Watch: AI Implications for Healthcare are Widespread Artificial Intelligence (AI) is key to building a better healthcare future, according to a recent survey of 500 U.S. healthcare leaders on their attitudes and usage of the technologies. Most — 94% — responded that their organizations continue […]

Innovator’s Corner

January 1, 2019

Modifying the Immune Response in Celiac Leslie Williams, CEO of ImmusanT, discusses the company’s research for developing a disease-modifying therapeutic for patients with celiac disease. Celiac disease is often misunderstood as a lifestyle disease. Unmanaged, celiac can result in chronic anemia, osteoporosis, defective dental enamel issues on the teeth, malnutrition, and other issues related to […]

Last Word

January 1, 2019

Combating Opioid Addiction Sarah Akerman, M.D., Senior Medical Director at Alkermes, talks about the industry’s role in opioid use disorder. PV: What are some of the biggest issues around the current treatment system for addiction? Akerman: The current treatment system for opioid addiction is inadequate; there is a lack of scientific innovation in this field. […]

Artificial Intelligence: Molecule to Market

January 1, 2019

The adoption of artificial intelligence (AI) is rapidly taking hold across global businesses, including the life-sciences industry. AI is typically defined as the ability of a machine to perform cognitive functions associated with human minds, such as perceiving, reasoning, learning, and problem solving. AI also includes a range of capabilities to solve business problems. According […]

SHOWCASE: Social Media: A Strategic Approach: Key to Social Media Success

January 1, 2019

Data from the second quarter of 2018 show that Facebook had 2.23 billion monthly active users, while Twitter had 326 million active users in the third quarter of 2018. Consumers use social media for many reasons today, including to learn about a medicine or illness. The use of social media forums is maturing and many […]

2019 Social Media Trends for Pharma

January 1, 2019

In a relatively short period of time, social media has reshaped communication for consumers and healthcare professionals alike. No longer are users simply posting content and communicating amongst themselves — social channels are now dominated by media reaching specifically targeted audiences. Looking forward to what lies ahead in the social space, we have compiled the […]

Drug Pricing Transparency: Will it be Now or Never?

January 1, 2019

In the ongoing clash between pharma and the Trump administration over pricing issues, CMS proposed a rule last year that would require pharmaceutical companies to include the price of any drug that cost more than $35 a month in their television ads. PhRMA preempted the salvo with a voluntary pledge to provide information in DTC […]

The Coming Wave of Cannabis-based Medicines

January 1, 2019

Cannabis has remained a source of controversy — from debates on its medicinal value and legalization to concerns about dependency. Cannabis is a hot-button issue among patients, healthcare practitioners, and policymakers. But that is changing. In fact, 32 states and Washington, D.C., now allow marijuana to be prescribed for medical purposes, although their approaches differ. […]

Breaking the Glass Ceiling: Why Diversity is a Business Imperative

January 1, 2019

If verbal assurances were translated into reality, U.S. businesses would be well-ahead of the game when it comes to diversity and inclusion. But that’s just not the case. Unfortunately, a comprehensive study from McKinsey found that far from making progress, gender diversity has stalled. For a 2018 survey, 279 companies with more than 13 million […]

Red Zone: To Gain Competitive Advantage, Learn Your ABCDs

January 1, 2019

Understanding and staying engaged with patients throughout their treatment and wellness journey is a primary focus of the entire life sciences industry. The benefits are clear: • Patients’ trust in the therapy and its ecosystem grows • Longitudinal data on patient progress provides evidence for value-based contracts • Pharma manufacturers gain “stickiness’ with patients and […]

FEEDBACK